Multiobjective evolutionary optimization in antibody purification process design
暂无分享,去创建一个
Suzanne S. Farid | Ana S. Simaria | Richard Allmendinger | A. S. Simaria | R. Allmendinger | S. Farid
[1] E Vásquez-Alvarez,et al. Efficient MILP formulations for the optimal synthesis of chromatographic protein purification processes. , 2004, Journal of biotechnology.
[2] David J Roush,et al. Maximizing productivity of chromatography steps for purification of monoclonal antibodies , 2008, Biotechnology and bioengineering.
[3] Suzanne S Farid,et al. A computer‐aided approach to compare the production economics of fed‐batch and perfusion culture under uncertainty , 2006, Biotechnology and bioengineering.
[4] Kalyanmoy Deb,et al. A fast and elitist multiobjective genetic algorithm: NSGA-II , 2002, IEEE Trans. Evol. Comput..
[5] Martin Smith,et al. Decisional tool to assess current and future process robustness in an antibody purification facility , 2012, Biotechnology progress.
[6] Peter J. Fleming,et al. On the Performance Assessment and Comparison of Stochastic Multiobjective Optimizers , 1996, PPSN.
[7] Suzanne S. Farid,et al. Modelling biopharmaceutical manufacture: Design and implementation of SimBiopharma , 2007, Comput. Chem. Eng..
[8] Marcus Degerman,et al. A Model‐Based Approach to Determine the Design Space of Preparative Chromatography , 2009 .
[9] Deborah K Follman,et al. Factorial screening of antibody purification processes using three chromatography steps without protein A. , 2004, Journal of chromatography. A.
[10] L C Eaton,et al. Host cell contaminant protein assay development for recombinant biopharmaceuticals. , 1995, Journal of chromatography. A.
[11] Anurag S. Rathore. Resin screening to optimize chromatographic separations , 2001 .
[12] J. Bonnerjea,et al. Scale-up of monoclonal antibody purification processes. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] Adele P. Peskin,et al. Optimization of large-scale chromatography for biotechnological applications , 1992 .
[14] Jürgen Hubbuch,et al. High Throughput Screening for the Design and Optimization of Chromatographic Processes: Automated Optimization of Chromatographic Phase Systems , 2009 .
[15] Suzanne S. Farid,et al. Efficient Discovery of Chromatography Equipment Sizing Strategies for Antibody Purification Processes Using Evolutionary Computing , 2012, PPSN.
[16] Suzanne S. Farid,et al. A multi-level meta-heuristic algorithm for the optimisation of antibody purification processes , 2012 .
[17] Suzanne S. Farid,et al. Dynamic Simulation Framework for Design of Lean Biopharmaceutical Manufacturing Operations , 2009 .
[18] A. Hunter,et al. Host cell proteins in biologics development: Identification, quantitation and risk assessment , 2009, Biotechnology and bioengineering.
[19] Lazaros G. Papageorgiou,et al. Optimal synthesis of chromatographic trains for downstream protein processing , 2011, Biotechnology progress.
[20] J A Asenjo,et al. Is there a rational method to purify proteins? From expert systems to proteomics , 2004, Journal of molecular recognition : JMR.
[21] Sanchayita Ghose,et al. Defining process design space for a hydrophobic interaction chromatography (HIC) purification step: Application of quality by design (QbD) principles , 2010, Biotechnology and bioengineering.
[22] M.H.M. Eppink,et al. Platform Technology for Developing Purification Processes , 2009 .
[23] Manfred Kurz. Regulatory considerations regarding quality aspects of monoclonal antibodies , 2007 .
[24] J. Hintze,et al. Violin plots : A box plot-density trace synergism , 1998 .
[25] Gonzalo Guillén-Gosálbez,et al. Hybrid simulation-optimization based approach for the optimal design of single-product biotechnological processes , 2012, Comput. Chem. Eng..
[26] Abhinav A Shukla,et al. Recent advances in large-scale production of monoclonal antibodies and related proteins. , 2010, Trends in biotechnology.
[27] Kenneth Alan De Jong,et al. An analysis of the behavior of a class of genetic adaptive systems. , 1975 .
[28] P. Hinckley,et al. Host cell protein clearance during protein a chromatography: Development of an improved column wash step , 2008, Biotechnology progress.
[29] Jie Chen,et al. The distinctive separation attributes of mixed-mode resins and their application in monoclonal antibody downstream purification process. , 2010, Journal of chromatography. A.
[30] Suzanne S Farid,et al. Decision‐Support Tool for Assessing Biomanufacturing Strategies under Uncertainty: Stainless Steel versus Disposable Equipment for Clinical Trial Material Preparation , 2008, Biotechnology progress.
[31] M Vanderlaan,et al. Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes , 2001, Biotechnology & genetic engineering reviews.
[32] P A Marichal-Gallardo,et al. State‐of‐the‐art in downstream processing of monoclonal antibodies: Process trends in design and validation , 2012, Biotechnology progress.
[33] David W. Corne,et al. Quantifying the Effects of Objective Space Dimension in Evolutionary Multiobjective Optimization , 2007, EMO.
[34] Marcel Ottens,et al. Design strategies for integrated protein purification processes: challenges, progress and outlook , 2008 .
[35] Nigel J. Titchener-Hooker,et al. A framework for assessing the solutions in chromatographic process design and operation for large-scale manufacture , 2006 .
[36] Beckley K. Nfor,et al. Model‐based rational strategy for chromatographic resin selection , 2011, Biotechnology progress.
[37] Yuhong Zhou,et al. Application of a Decision‐Support Tool to Assess Pooling Strategies in Perfusion Culture Processes under Uncertainty , 2008, Biotechnology progress.
[38] Seppo Ylä-Herttuala,et al. Challenges in monoclonal antibody-based therapies , 2009, Annals of medicine.
[39] Melanie Mitchell,et al. An introduction to genetic algorithms , 1996 .